Plegridy FDA Approval History
Last updated by Judith Stewart, BPharm on Feb 3, 2021.
Plegridy (peginterferon beta-1a) is a pegylated interferon beta indicated for the treatment of patients with relapsing forms of multiple sclerosis.
Development Timeline for Plegridy
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.